Short-Chain Fatty Acids as a Potential Treatment for Infections: a Closer Look at the Lungs

Short-chain fatty acids (SCFAs) are the main metabolites produced by the gut microbiota via the fermentation of complex carbohydrates and fibers. Evidence suggests that SCFAs play a role in the control of infections through direct action both on microorganisms and on host signaling. This review summ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infection and immunity Jg. 89; H. 9; S. e0018821
Hauptverfasser: Machado, Marina Gomes, Sencio, Valentin, Trottein, François
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 16.08.2021
Schlagworte:
ISSN:1098-5522, 1098-5522
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Short-chain fatty acids (SCFAs) are the main metabolites produced by the gut microbiota via the fermentation of complex carbohydrates and fibers. Evidence suggests that SCFAs play a role in the control of infections through direct action both on microorganisms and on host signaling. This review summarizes the main microbicidal effects of SCFAs and discusses studies highlighting the effect of SCFAs in the virulence and viability of microorganisms. We also describe the diverse and complex modes of action of the SCFAs on the immune system in the face of infections with a specific focus on bacterial and viral respiratory infections. A growing body of evidence suggests that SCFAs protect against lung infections. Finally, we present potential strategies that may be leveraged to exploit the biological properties of SCFAs for increasing effectiveness and optimizing patient benefits.
AbstractList Short-chain fatty acids (SCFAs) are the main metabolites produced by the gut microbiota via the fermentation of complex carbohydrates and fibers. Evidence suggests that SCFAs play a role in the control of infections through direct action both on microorganisms and on host signaling. This review summarizes the main microbicidal effects of SCFAs and discusses studies highlighting the effect of SCFAs in the virulence and viability of microorganisms. We also describe the diverse and complex modes of action of the SCFAs on the immune system in the face of infections with a specific focus on bacterial and viral respiratory infections. A growing body of evidence suggests that SCFAs protect against lung infections. Finally, we present potential strategies that may be leveraged to exploit the biological properties of SCFAs for increasing effectiveness and optimizing patient benefits.Short-chain fatty acids (SCFAs) are the main metabolites produced by the gut microbiota via the fermentation of complex carbohydrates and fibers. Evidence suggests that SCFAs play a role in the control of infections through direct action both on microorganisms and on host signaling. This review summarizes the main microbicidal effects of SCFAs and discusses studies highlighting the effect of SCFAs in the virulence and viability of microorganisms. We also describe the diverse and complex modes of action of the SCFAs on the immune system in the face of infections with a specific focus on bacterial and viral respiratory infections. A growing body of evidence suggests that SCFAs protect against lung infections. Finally, we present potential strategies that may be leveraged to exploit the biological properties of SCFAs for increasing effectiveness and optimizing patient benefits.
Short-chain fatty acids (SCFAs) are the main metabolites produced by the gut microbiota via the fermentation of complex carbohydrates and fibers. Evidence suggests that SCFAs play a role in the control of infections through direct action both on microorganisms and on host signaling. This review summarizes the main microbicidal effects of SCFAs and discusses studies highlighting the effect of SCFAs in the virulence and viability of microorganisms. We also describe the diverse and complex modes of action of the SCFAs on the immune system in the face of infections with a specific focus on bacterial and viral respiratory infections. A growing body of evidence suggests that SCFAs protect against lung infections. Finally, we present potential strategies that may be leveraged to exploit the biological properties of SCFAs for increasing effectiveness and optimizing patient benefits.
Author Trottein, François
Sencio, Valentin
Machado, Marina Gomes
Author_xml – sequence: 1
  givenname: Marina Gomes
  surname: Machado
  fullname: Machado, Marina Gomes
  organization: Laboratory of Immunopharmacology, Department of Biochemistry and Immunology, ICB, Federal University of Minas Gerais, Belo Horizonte, Brazil
– sequence: 2
  givenname: Valentin
  surname: Sencio
  fullname: Sencio, Valentin
  organization: Centre d'Infection et d'Immunité de Lille, INSERM U1019, CNRS UMR 9017, University of Lille, CHU Lille, Institut Pasteur de Lille, Lille, France
– sequence: 3
  givenname: François
  surname: Trottein
  fullname: Trottein, François
  organization: Centre d'Infection et d'Immunité de Lille, INSERM U1019, CNRS UMR 9017, University of Lille, CHU Lille, Institut Pasteur de Lille, Lille, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34097474$$D View this record in MEDLINE/PubMed
BookMark eNpNkE1LxDAYhIOsuB968yw5eumapAlJvC3F1UJBwfXkoaTZ1FbbZE3Sw_57A64gDMw78DDwzhLMrLMGgGuM1hgTcVduyjVCWIiM4DOwwEiKjDFCZv_uOViG8JkoSqm4APOcIskppwvw_to5H7OiU72FWxXjEW50vw9QJcEXF42NvRrgzhsVxxRg6zwsbWt07J0N94kqBheMh5VzX1BFGDsDq8l-hEtw3qohmKuTr8Db9mFXPGXV82NZbKpMMYJjlgtNccOFFOkJqjluBeJEIIm1MI3ERjJJFOGoRSxneYNbRButWaNzQhVWZAVuf3sP3n1PJsR67IM2w6CscVOoCcslQUJwlNCbEzo1o9nXB9-Pyh_rv0HID0n3YUE
CitedBy_id crossref_primary_10_3389_fimmu_2022_773261
crossref_primary_10_1016_j_ijbiomac_2024_131958
crossref_primary_10_3892_etm_2022_11536
crossref_primary_10_1111_1751_7915_70147
crossref_primary_10_1016_j_biopha_2023_115276
crossref_primary_10_1371_journal_ppat_1013453
crossref_primary_10_1080_19490976_2024_2361660
crossref_primary_10_1007_s40473_024_00292_9
crossref_primary_10_1159_000542807
crossref_primary_10_1016_j_ucl_2024_07_016
crossref_primary_10_1080_19490976_2021_2018900
crossref_primary_10_3389_fcimb_2023_1149679
crossref_primary_10_3389_fimmu_2024_1347676
crossref_primary_10_1038_s41598_024_78992_1
crossref_primary_10_3390_environments11070145
crossref_primary_10_1111_wrr_13208
crossref_primary_10_4014_jmb_2301_01031
crossref_primary_10_1016_j_fbio_2024_103665
crossref_primary_10_1016_j_micpath_2025_107835
crossref_primary_10_1186_s41231_024_00167_x
crossref_primary_10_3390_nu14071478
crossref_primary_10_1016_j_tvjl_2025_106320
crossref_primary_10_3389_fnut_2024_1330903
crossref_primary_10_3390_ani15010103
crossref_primary_10_1007_s00216_022_04217_x
crossref_primary_10_3390_ijms25094817
crossref_primary_10_1016_j_jaci_2024_04_029
crossref_primary_10_1016_j_tube_2025_102652
crossref_primary_10_3389_fcimb_2022_815715
crossref_primary_10_3389_fmicb_2023_1292266
crossref_primary_10_1016_j_biopha_2023_114414
crossref_primary_10_1016_j_cell_2025_08_001
crossref_primary_10_1016_j_tim_2024_10_001
crossref_primary_10_3390_ijms23094768
crossref_primary_10_1007_s00284_022_03029_7
crossref_primary_10_33073_pjm_2025_011
crossref_primary_10_1039_D4FO04028G
crossref_primary_10_3389_fphar_2022_1020133
crossref_primary_10_1016_j_cbi_2022_110231
crossref_primary_10_3390_ijms24021716
crossref_primary_10_1038_s41598_023_45340_8
crossref_primary_10_3389_fmicb_2025_1632412
crossref_primary_10_1371_journal_pone_0313090
crossref_primary_10_1186_s12967_024_05376_4
crossref_primary_10_3390_jof11050333
crossref_primary_10_1016_j_jiph_2025_102840
crossref_primary_10_1016_j_biopha_2023_114916
crossref_primary_10_1016_j_imlet_2023_06_002
crossref_primary_10_1038_s41579_024_01058_6
crossref_primary_10_3389_fevo_2023_1126243
crossref_primary_10_3389_fimmu_2022_841532
crossref_primary_10_1016_j_fbio_2025_106914
crossref_primary_10_31083_j_fbl2902059
crossref_primary_10_3389_fmicb_2023_1125616
crossref_primary_10_3390_nu14235033
crossref_primary_10_1128_IAI_00356_21
crossref_primary_10_1186_s12964_025_02367_w
crossref_primary_10_1016_j_jff_2025_107010
crossref_primary_10_1371_journal_ppat_1011160
crossref_primary_10_1016_j_addr_2023_114896
crossref_primary_10_3390_biomedicines12081779
crossref_primary_10_1038_s41467_022_35767_4
crossref_primary_10_1111_apha_14266
crossref_primary_10_1002_jmv_70192
crossref_primary_10_3390_nu16081159
crossref_primary_10_1002_fsn3_70292
crossref_primary_10_1038_s41579_024_01048_8
crossref_primary_10_3390_ijms23031022
crossref_primary_10_1016_j_aquaculture_2024_740581
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1128/IAI.00188-21
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-5522
ExternalDocumentID 34097474
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Agence Nationale de la Recherche (ANR)
  grantid: ANR-17-CE15-0020-01
– fundername: Agence Nationale de la Recherche (ANR)
  grantid: AM-COV-PATH
GroupedDBID ---
-DZ
-~X
.55
0R~
18M
29I
2WC
39C
4.4
53G
5GY
5RE
5VS
85S
ABOCM
ACGFO
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
L7B
NPM
O9-
OK1
P2P
RHF
RHI
RNS
RPM
RSF
SJN
TR2
TWZ
UCJ
UPT
VQA
W2D
W8F
WH7
WOQ
X7M
YIF
~KM
7X8
AAGFI
ID FETCH-LOGICAL-a521t-38c41b78981884c71f80728091c8eb91e9592a270f05353b1f04bcc5bc324a1a2
IEDL.DBID 7X8
ISICitedReferencesCount 83
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000707999200007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1098-5522
IngestDate Wed Oct 01 13:41:09 EDT 2025
Wed Feb 19 02:26:33 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords short-chain fatty acid
bacteria
virus
gut
respiratory infection
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a521t-38c41b78981884c71f80728091c8eb91e9592a270f05353b1f04bcc5bc324a1a2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/8370681
PMID 34097474
PQID 2539208870
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2539208870
pubmed_primary_34097474
PublicationCentury 2000
PublicationDate 20210816
PublicationDateYYYYMMDD 2021-08-16
PublicationDate_xml – month: 8
  year: 2021
  text: 20210816
  day: 16
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Infection and immunity
PublicationTitleAlternate Infect Immun
PublicationYear 2021
SSID ssj0014448
Score 2.6050155
SecondaryResourceType review_article
Snippet Short-chain fatty acids (SCFAs) are the main metabolites produced by the gut microbiota via the fermentation of complex carbohydrates and fibers. Evidence...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage e0018821
SubjectTerms Animals
Anti-Infective Agents - immunology
Anti-Infective Agents - metabolism
Anti-Infective Agents - therapeutic use
Fatty Acids, Volatile - immunology
Fatty Acids, Volatile - metabolism
Fatty Acids, Volatile - therapeutic use
Humans
Infections - drug therapy
Infections - immunology
Infections - microbiology
Lung - drug effects
Lung - immunology
Lung - microbiology
Lung - virology
Microbial Viability
Respiratory Tract Infections - drug therapy
Respiratory Tract Infections - immunology
Respiratory Tract Infections - microbiology
Respiratory Tract Infections - virology
Signal Transduction - immunology
Virulence
Title Short-Chain Fatty Acids as a Potential Treatment for Infections: a Closer Look at the Lungs
URI https://www.ncbi.nlm.nih.gov/pubmed/34097474
https://www.proquest.com/docview/2539208870
Volume 89
WOSCitedRecordID wos000707999200007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qVHzxfpk3IvgabNqkTXyRMRwOtjHwwsCHkmYNDqRVW4X9e89ZW3wSBKGUPqSlJOfykfPlfIRcBkEoQhlx5pwvmbDwlISaM5VMIy7d1JlFK6WnQTQaqclEj-sNt6KmVTYxcRGop7nFPfIrX0ImR5fwbt7eGapGYXW1ltBYJq0AoAw6ZjT5qSIIIaqjcFoxCUCjIb776qrf6WMRAs2E_w4uF0mmt_Xf39smmzW8pJ3KHnbIUprtkrVKcHK-S9aHdSl9jzzfvwDyZt0XM8toz5TlnHbsbFpQAxcd5yXSiOBTDw0TnQK8pf2au5UV1zCq-5qDBdMBAHVqSgpYkg4geBT75LF3-9C9Y7XSAjMoaMACZQVPIqUhfStcMKc81K3S3Ko00TzVUvvGjzyH7WCChDtPJNbKxAIeM9z4B2Qly7P0iFCrnGeUdIEEpOXrUIWpiwKNJ3CVNca2yUUzgTFYMpYnTJbmn0X8M4VtclitQvxWtdyIA2zLJSJx_Ie3T8iGj8QT7FsbnpKWAz9Oz8iq_Spnxcf5wkTgPhoPvwEpCMKp
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Short-Chain+Fatty+Acids+as+a+Potential+Treatment+for+Infections%3A+a+Closer+Look+at+the+Lungs&rft.jtitle=Infection+and+immunity&rft.au=Machado%2C+Marina+Gomes&rft.au=Sencio%2C+Valentin&rft.au=Trottein%2C+Fran%C3%A7ois&rft.date=2021-08-16&rft.issn=1098-5522&rft.eissn=1098-5522&rft.volume=89&rft.issue=9&rft.spage=e0018821&rft_id=info:doi/10.1128%2FIAI.00188-21&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-5522&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-5522&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-5522&client=summon